Kyowa Kirin Co Ltd banner

Kyowa Kirin Co Ltd
DUS:KY4

Watchlist Manager
Kyowa Kirin Co Ltd Logo
Kyowa Kirin Co Ltd
DUS:KY4
Watchlist
Price: 15.3 EUR
Market Cap: €13.7B

Profitability Summary

Kyowa Kirin Co Ltd's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Kyowa Kirin Co Ltd

Margins Comparison
Kyowa Kirin Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
Kyowa Kirin Co Ltd
TSE:4151
1.5T JPY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
976.4B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
590.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
294.6B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
306.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.2B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.7B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Kyowa Kirin Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Kyowa Kirin Co Ltd
TSE:4151
1.5T JPY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
976.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
590.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
294.6B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
306.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.7B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Kyowa Kirin Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett